# Fel d 1-specific capture and biotin-labeled detection monoclonal antibodies suitable for use in Enzyme Linked Immunosorbent Assay (ELISA/ImmunoEnzymetric Assay (IEMA)

Canonical: https://abierto.us/opportunities/fdarfq125149

- Solicitation number: FDARFQ125149
- Notice type: Combined synopsis and solicitation
- Status: Awarded to Iggenix, Inc.
- Department: Department of Health and Human Services
- Agency: Food and Drug Administration
- Contracting office: FDA Center for Biologics Evaluation and Research (75DKKB)
- NAICS: 325414 Biological Product (except Diagnostic) Manufacturing
- Product or service code: 6515 Medical and Surgical Instruments, Equipment, and Supplies
- Place of performance: Silver Spring, Maryland
- County: Montgomery County (FIPS 24031). https://abierto.us/counties/montgomery-county-md-24031
- City: Silver Spring. https://abierto.us/cities/silver-spring-md-2472450
- First posted: August 23, 2024
- Last posted: August 28, 2024
- SAM.gov: https://sam.gov/workspace/contract/opp/6ce04e6f70b64272abf04c589cbf2006/view

## Description

Purchase Fel d 1-specific capture and biotin-labeled detection monoclonal antibodies suitable for use in Enzyme Linked Immunosorbent Assay (ELISA/ImmunoEnzymetric Assay (IEMA)

**8/28/2024:**

**Contractor Question and Government Response:** Does the product need to be an existing off-the shelf material, or can it be custom-developed for this RFQ? Can the host species be rabbit?

**GOVERNMENT RESPONSE:** The product can be off the shelf The product should be human origin, not rabbit or mouse.

## Award on USAspending

- Recipient: Iggenix, Inc. (UEI HBP9HFYHB3Q4)
- Contract: 75F40124P00438, purchase order
- Obligated: $100,000.00
- Competition: Competed Under SAP, 1 offers received
- Link: solicitation number FDARFQ125149 equals the FPDS solicitation identifier; same sub-agency 7524 (high confidence)
- Record: https://www.usaspending.gov/award/CONT_AWD_75F40124P00438_7524_-NONE-_-NONE-/


## Publications

- August 23, 2024: Combined synopsis and solicitation, due August 30, 2024 at 2:00 PM EDT. Notice d3a8330e564d43428da07a1ab5326196. https://sam.gov/workspace/contract/opp/d3a8330e564d43428da07a1ab5326196/view
- August 28, 2024: Combined synopsis and solicitation, due August 30, 2024 at 2:00 PM EDT. Notice 6ce04e6f70b64272abf04c589cbf2006. https://sam.gov/workspace/contract/opp/6ce04e6f70b64272abf04c589cbf2006/view

## Points of contact

- Howard S. Yablon, howard.yablon@fda.hhs.gov, 2404027630

---
Source: SAM.gov Contract Opportunities bulk extract and USAspending.gov award data. Confirm deadlines on SAM.gov before responding. Cite https://abierto.us/opportunities/fdarfq125149.